Evidence map›Paper›PMID 25888899›Full record

ArticleVeterinary research2015

PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.

Hanna C Koinig, Stephanie C Talker, Maria Stadler, Andrea Ladinig, Robert Graage, Mathias Ritzmann, Isabel Hennig-Pauka, Wilhelm Gerner, Armin Saalmüller

Open access · goldAbstract read
In one paragraph

Article in Veterinary research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Vaccination and Infection of Swine WithFrontiers in immunology · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hanna C KoinigUniversity Clinic for Swine, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine, Vienna, Austria. hanna.koinig@vetmeduni.ac.at.
Stephanie C TalkerInstitute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria. stephanie.talker@vetmeduni.ac.at.
Maria StadlerInstitute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria. maria.stadler@vetmeduni.ac.at.
Andrea LadinigUniversity Clinic for Swine, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine, Vienna, Austria. andrea.ladinig@vetmeduni.ac.at.
Robert GraageUniversity Clinic for Swine, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine, Vienna, Austria. robert.graage@uzh.ch.
Mathias RitzmannUniversity Clinic for Swine, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine, Vienna, Austria. M.Ritzmann@lmu.de.
Isabel Hennig-PaukaUniversity Clinic for Swine, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine, Vienna, Austria. isabel.hennig-pauka@vetmeduni.ac.at.
Wilhelm GernerInstitute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria. wilhelm.gerner@vetmeduni.ac.at.
Armin SaalmüllerInstitute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria. armin.saalmueller@vetmeduni.ac.at.
University of Veterinary Medicine Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porcine circovirus type 2 (PCV2) is one of the economically most important pathogens for swine production worldwide. Vaccination is a powerful tool to control porcine circovirus diseases (PCVD). However, it is not fully understood how PCV2 vaccination interacts with the porcine immune system. Especially knowledge on the cellular immune response against PCV2 is sparse. In this study we analysed antigen-specific T cell responses against PCV2 in a controlled vaccination and infection experiment. We focused on the ability of CD4(+) T cells to produce cytokines using multicolour flow cytometry (FCM). Vaccination with a PCV2 subunit vaccine (Ingelvac CircoFLEX®) induced PCV2-specific antibodies only in five out of 12 animals. Conversely, vaccine-antigen specific CD4(+) T cells which simultaneously produced IFN-γ and TNF-α and had a phenotype of central and effector memory T cells were detected in all vaccinated piglets. After challenge, seroconversion occurred earlier in vaccinated and infected pigs compared to the non-vaccinated, infected group. Vaccinated pigs were fully protected against viremia after subsequent challenge. Therefore, our data suggests that the induction of IFN-γ/TNF-α co-producing T cells by PCV2 vaccination may serve as a potential correlate of protection for this type of vaccine.

Indexed as

Immunity, CellularImmunity, HumoralAnimalsCD4-Positive T-LymphocytesCircoviridae InfectionsCircovirusFlow CytometryInterferon-gammaPolymerase Chain ReactionSwineSwine DiseasesTumor Necrosis Factor-alphaVaccinationVaccines, SubunitViral LoadViral VaccinesInterferon-gammaTumor Necrosis Factor-alphaVaccines, SubunitViral Vaccines

Identifiers

PMID25888899
PMCPMC4348102
OpenAlexW2148761578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.